Pancreatic Cancer Research

ResearcherGuiyang Medical UniversityActive in the last 2 years

Peng Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5490-7343; OpenAlex author ID A5100346739. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 1 paper

Papers 4

  1. PSMD14-Mediated LDHA Deubiquitination Upregulates ACLY Expression via H3K18 Lactylation to Promote Lipid Synthesis and Pancreatic Cancer Progression. Co-author DOI 10.1002/advs.202505762↗
  2. The deubiquitinating enzyme MINDY2 promotes pancreatic cancer proliferation and metastasis by stabilizing ACTN4 expression and activating the PI3K/AKT/mTOR sig… Co-author DOI 10.3389/fonc.2023.1169833↗
  3. The long non-coding RNA EGOT promotes pancreatic cancer progression by sequestering miR-214 to derepress PLS3 expression Co-author DOI 10.21203/rs.3.rs-1415870/v1↗
  4. Serum lncRNA-UFC1 as a potential biomarker for diagnosis and prognosis of pancreatic cancer. Co-author PMID 31933809↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiaobin Fei · 2 shared papers, 2023–2025 · strength 0.42
  2. Xing Wang · 1 shared paper, 2025 · strength 0.24
  3. Rishang Lu · 1 shared paper, 2025 · strength 0.24
  4. Yongjia Gao · 1 shared paper, 2025 · strength 0.24
  5. Yaozhen Pan · 1 shared paper, 2025 · strength 0.24
  6. Songbai Liu · 1 shared paper, 2023 · strength 0.18
  7. Yaozhen Pan · 1 shared paper, 2023 · strength 0.18
  8. Zechang Xin · 1 shared paper, 2022 · strength 0.16
  9. Lijie Cai · 1 shared paper, 2022 · strength 0.16
  10. Jianjun Qian · 1 shared paper, 2022 · strength 0.16
  11. Jie J. Yao · 1 shared paper, 2022 · strength 0.16
  12. Zhennan Li · 1 shared paper, 2022 · strength 0.16
  13. Ming Chen · 1 shared paper, 2019 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.